LEAN Cell & Gene Summit Series Expands Following Successful Boston Debut Next event to take place in National Harbor, MD, November 6, 2025
Boston, MA | October 9, 2025 – Following the success of the inaugural LEAN Cell & Gene Summit in Boston, the event series is set to continue in National Harbor, Maryland, on November 6, 2025, with the LEAN Cell & Gene D.C. Summit.
The Boston event brought together thought leaders from Cabaletta Bio, Takeda, Regeneron, BioNTech, and Orca Bio, sparking vital discussions on how the cell and gene therapy (CGT) sector can achieve true scalability in manufacturing. The strong engagement and sense of urgency underscored a growing reality across the industry: developers are under increasing pressure to deliver advanced therapies faster, more affordably, and at scale.
Building on that momentum, the upcoming D.C. Summit will explore the practical application of LEAN manufacturing principles within CGT operations. The one-day meeting will feature case studies, technical sessions, and expert panels focused on reducing waste, improving flexibility, and accelerating technology transfer across the CGT value chain.
Key sessions will include:
- Comparing & Contrasting CGT Production Systems: uncovering hidden inefficiencies and leveraging modularity for manufacturing flexibility
- Case Studies in TCR-T, TIL, and CAR-T Manufacturing: spanning cytokine innovation, scalable TIL processes, modular tech transfer, and PAT-enabled real-time monitoring
- Next-Gen Analytics: advancing automated potency assays and high-throughput flow cytometry to reduce variability
With capital preservation now a top priority and manufacturing platforms under heightened scrutiny, the LEAN Cell & Gene D.C. Summit will offer actionable frameworks to help developers adopt proven LEAN methodologies long established in other industries.
Conveniently scheduled the day before SITC 2025, this focused one-day event provides CGT leaders a timely opportunity to address the operational and manufacturing challenges that will determine whether advanced therapies can truly scale to meet patient demand.
Registration information is available here.
About the LEAN Cell & Gene Summit Series
The LEAN Cell & Gene Summit Series convenes leaders from across the biopharma and CGT landscape to explore the adoption of LEAN manufacturing principles that drive efficiency, scalability, and sustainability in advanced therapy production.